AMARIN CORP PLC\UK Accounts Payable
AMARIN CORP PLC\UK (AMRN) had Accounts Payable of $18.80 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-07-29
- 2026-06-30: Accounts Payable, Current $18.80M.
- 2026-03-31: Accounts Payable, Current $48.15M.
- 2025-12-31: Accounts Payable, Current $45.35M.
- 2025-09-30: Accounts Payable, Current $36.71M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $18.80M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $48.15M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $45.35M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $36.71M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $44.71M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $45.66M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $40.37M 10-K · filed 2026-03-02 |
| 2024-09-30 | $40.51M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $54.38M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $67.60M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $52.76M 10-K · filed 2025-03-12 |
| 2023-09-30 | $53.36M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $54.31M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $58.78M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $64.60M 10-K · filed 2024-02-29 |
| 2022-09-30 | $93.16M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $116.31M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $90.75M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $114.92M 10-K · filed 2023-03-01 |
| 2021-09-30 | $72.42M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $141.25M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $94.26M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $105.88M 10-K · filed 2022-03-01 |
| 2020-09-30 | $121.37M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $86.76M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $98.33M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $49.95M 10-K · filed 2021-02-25 |
| 2019-09-30 | $42.04M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $34.02M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $26.78M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $37.63M 10-K · filed 2020-02-25 |
| 2018-09-30 | $26.17M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $34.47M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $31.88M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $25.16M 10-K · filed 2019-02-27 |
| 2017-09-30 | $15.80M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $16.45M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $15.12M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $6.06M 10-K · filed 2018-02-27 |
| 2016-09-30 | $6.86M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $14.81M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $15.14M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $10.83M 10-K · filed 2017-03-01 |
| 2015-09-30 | $17.90M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $13.01M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $10.76M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $8.53M 10-K · filed 2016-02-25 |
| 2014-09-30 | $6.06M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $5.54M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $4.82M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $6.38M 10-K · filed 2015-03-03 |
| 2013-09-30 | $6.23M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $9.69M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $22.95M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $17.46M 10-K · filed 2014-02-27 |
| 2012-09-30 | $13.70M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $8.43M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $4.57M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $4.42M 10-K · filed 2013-02-28 |
| 2011-09-30 | $3.84M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $1.93M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $4.45M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |